LOMBARD MEDICAL LIMITED
Get an alert when LOMBARD MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-06 (in 9mo)
Last made up 2026-01-23
Watchouts
None on the register
Cash
£824K
-12.3% vs 2023
Net assets
£2M
+116.9% vs 2023
Employees
46
-4.2% vs 2023
Profit before tax
-£2M
-190.7% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £12,168,000 | £13,495,000 | |
| Operating profit | -£458,000 | -£2,134,000 | |
| Profit before tax | -£755,000 | -£2,195,000 | |
| Net profit | -£762,000 | -£2,199,000 | |
| Cash | £940,000 | £824,000 | |
| Total assets less current liabilities | -£5,451,000 | £1,755,000 | |
| Net assets | -£9,071,000 | £1,533,000 | |
| Equity | -£9,071,000 | £1,533,000 | |
| Average employees | 48 | 46 | |
| Wages | £2,945,000 | £2,875,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -3.8% | -15.8% | |
| Net margin | -6.3% | -16.3% | |
| Return on capital employed | 8.4% | -121.6% | |
| Gearing (liabilities / total assets) | 229.7% | 80.2% | |
| Current ratio | 0.53x | 1.23x | |
| Interest cover | -1.50x | -30.49x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements of the Company have been prepared on a going concern basis because the directors have a reasonable expectation that Lombard Medical Limited will be able to continue to fund the Company for a period of no less than 12 months from the date of approval of these financial statements.”
Significant events
- “Group restructure leading to a change in ultimate controlling party on 19 August 2024, with MicroPort Endovastec B.V. acquiring OMD shares.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 27 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PEARCE, Richard Michael | Secretary | 2018-08-17 | — | — |
| LI, Chunfang | Director | 2026-04-23 | Feb 1980 | Chinese |
| PEARCE, Richard Michael | Director | 2018-08-17 | May 1973 | English |
| ZHU, Qing | Director | 2024-11-01 | Jun 1981 | Chinese |
Show 27 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ARDILL, Ian Leslie | Secretary | 2012-02-29 | 2014-12-08 |
| CONNELLY, Rupert Oliver | Secretary | 1997-03-14 | 1999-05-14 |
| CONNELLY, Rupert Oliver | Secretary | 1995-03-10 | 1996-07-07 |
| DOWNIE, George Edward Alexander | Secretary | 1996-07-08 | 1997-03-05 |
| JONES, William Rhodri | Secretary | 2001-04-11 | 2012-02-29 |
| KULLBACK, William Jay | Secretary | 2014-12-08 | 2017-05-05 |
| BRIGHTON SECRETARY LIMITED | Corporate Nominee Secretary | 1994-12-06 | 1995-03-10 |
| EXCELLET INVESTMENTS LIMITED | Corporate Secretary | 1999-05-14 | 2001-04-11 |
| ANSON, Anthony Walter, Dr | Director | 1995-03-10 | 2006-05-02 |
| ARDILL, Ian Leslie | Director | 2012-01-23 | 2015-02-19 |
| CONNELLY, Rupert Oliver | Director | 1995-03-10 | 1999-11-09 |
| COOKE, Timothy Mirfield | Director | 1999-06-07 | 2001-04-11 |
| COOKE, Timothy Mirfield | Director | 1995-06-18 | 1996-06-08 |
| DOWNIE, George Edward Alexander | Director | 1995-03-10 | 1997-04-01 |
| HALL, Timothy Richard | Director | 2005-11-07 | 2011-12-31 |
| HAYES, Natalie Jayne, Dr | Director | 2022-06-01 | 2025-04-30 |
| HOWLETT, Brian | Director | 2005-11-11 | 2010-03-31 |
| HUBBERT, Simon | Director | 2011-01-01 | 2017-04-18 |
| KERSLAKE, John Wilfred Ernest | Director | 1999-10-18 | 2005-11-04 |
| KULLBACK, William Jay | Director | 2014-12-08 | 2017-05-05 |
| LEMVIGH, Kurt Bloch | Director | 2018-08-17 | 2025-02-24 |
| MURSALEEN, Zia | Director | 1999-10-18 | 2003-02-28 |
| PHILLIPS, Peter William, Dr | Director | 1995-09-25 | 2020-04-28 |
| RUSH, John Barry | Director | 2009-10-12 | 2010-12-31 |
| TAYLOR, Alistair Henderson | Director | 1998-10-01 | 2007-09-30 |
| TERRY, Stephen John | Director | 2002-12-05 | 2005-10-19 |
| BRIGHTON DIRECTOR LIMITED | Corporate Nominee Director | 1994-12-06 | 1995-03-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Richard Michael Pearce | Individual | Significant influence | 2018-01-26 | Ceased 2018-01-26 |
| Mr Kurt Bloch Lemvigh | Individual | Significant influence | 2018-01-26 | Ceased 2018-01-26 |
| Lombard Medical Technologies Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2018-04-25 |
| Cfo William J Kullback | Individual | Significant influence | 2016-04-06 | Ceased 2017-05-05 |
Filing timeline
Last 20 of 176 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-28 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-22 | AA | accounts | Accounts with accounts type full | |
| 2025-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-26 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-01-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-31 | AA | accounts | Accounts with accounts type full | |
| 2023-01-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-09-12 | AA | accounts | Accounts with accounts type small | |
| 2022-06-22 | AP01 | officers | Appoint person director company with name date | |
| 2022-04-06 | SH01 | capital | Capital allotment shares | |
| 2022-04-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-04-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-04-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-04-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-01-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-08-05 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+10.9%
£12,168,000 £13,495,000
-
Cash
-12.3%
£940,000 £824,000
-
Net assets
+116.9%
-£9,071,000 £1,533,000
-
Employees
-4.2%
48 46
-
Operating profit
-365.9%
-£458,000 -£2,134,000
-
Profit before tax
-190.7%
-£755,000 -£2,195,000
-
Wages
-2.4%
£2,945,000 £2,875,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers